ASND Ascendis Pharma A/S
$267.07
Ascendis Pharma A/S (ASND) Earnings News
Earnings press releases, previews and reviews for Ascendis Pharma A/S (ASND), newest first. Our most recent is review: Ascendis Pharma Beats as YORVIPATH Scales and Margins Jump, but the 42% Margin Flatters the Run Rate.
Thursday
November 12, 2026
10:41 AM ET
Ascendis Pharma Beats as YORVIPATH Scales and Margins Jump, but the 42% Margin Flatters the Run Rate
Earnings Whispers · Review
Thursday
November 12, 2026
7:30 AM ET
Ascendis Pharma Reports Third Quarter 2026 Financial Results
Friday
November 6, 2026
2:28 PM ET
Ascendis Faces Its First Clean Quarter After PRV Windfall as UVWell Ramp Takes Center Stage
Earnings Whispers · Preview
Thursday
November 5, 2026
4:01 PM ET
Ascendis to Report Third Quarter 2026 Financial Results and Provide Business Update on November 12, 2026
Thursday
August 13, 2026
7:30 AM ET
Ascendis Pharma Reports Second Quarter 2026 Financial Results
Thursday
August 6, 2026
4:01 PM ET
Ascendis to Report Second Quarter 2026 Financial Results and Provide Business Update on August 13, 2026